Dear Kenneth,

Traditional development programs can accumulate studies out of caution or convention. But not every study meaningfully contributes to patient safety, regulatory decision-making or phase-appropriate progression.

This IQVIA Insights Guide explores a practical framework for regulatory efficiency — helping sponsors distinguish between studies that are required, informative but deferrable, or non-decision-driving.